Evidence map›Paper›PMID 39273021›Full record

ArticleCells2024

Cell-Sonar, a Novel Method for Intracellular Tracking of Secretory Pathways.

Sabrina Brockmöller, Thomas Seeger, Franz Worek, Simone Rothmiller

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sabrina BrockmöllerBundeswehr Institute of Pharmacology and Toxicology, 80937 Munich, Bavaria, Germany.ORCID 0009-0008-4521-5474
Thomas SeegerBundeswehr Institute of Pharmacology and Toxicology, 80937 Munich, Bavaria, Germany.
Franz WorekBundeswehr Institute of Pharmacology and Toxicology, 80937 Munich, Bavaria, Germany.ORCID 0000-0003-3531-3616
Simone RothmillerBundeswehr Institute of Pharmacology and Toxicology, 80937 Munich, Bavaria, Germany.ORCID 0000-0003-2041-0034

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntracellular tracking is commonly used in trafficking research. Until today, the respective techniques have remained complex, and complicated, mostly transgenic target protein changes are necessary, often requiring expensive equipment and expert knowledge.

methodsWe present a novel method, which we term "cell-sonar", that enables the user to track expression changes of specific protein markers that serve as points of interaction. Our study provides comparable analyses of expression changes of these marker proteins by in-cell Western analyses in two otherwise isogenic cell lines that only differ in the overexpression of the tracked target protein. Using the overexpressed human adult muscle-type nicotinic acetylcholine receptor as an example, we demonstrate that cell-sonar can cover multiple intracellular compartments such as the endoplasmic reticulum, the pathway between it and the Golgi apparatus, and the endocytic pathway.

resultsWe provide evidence for receptor maturation in the Golgi and storage in recycling endosomes, rather than the fate of increased insertion into the plasma membrane. Additionally, we demonstrate with the implementation of nicotine that the receptor's destiny is exasperated up to secondary degradation.

conclusionsCell-sonar is an affordable, easy-to-implement, and cheap method that can be adapted to a broad variety of proteins and cellular pathways of interest to researchers.

Indexed as

Golgi ApparatusSecretory PathwayCell LineEndoplasmic ReticulumEndosomesHumansProtein TransportReceptors, NicotinicReceptors, Nicotiniccellular trackingnicotinic acetylcholine receptorprotein homeostasis

Identifiers

PMID39273021
PMCPMC11394445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.